메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Pichamol Jirapinyo (Brigham and Women’s Hospital) Diogo T. H. de Moura (Brigham and Women’s Hospital) Laura C. Horton (Brigham and Women’s Hospital) Christopher C. Thompson (Brigham and Women’s Hospital)
저널정보
대한소화기내시경학회 Clinical Endoscopy Clinical Endoscopy 제53권 제6호
발행연도
2020.1
수록면
686 - 697 (12page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: Aspiration therapy (AT) involves endoscopic placement of a gastrostomy tube with an external device that allows patients to drain 30% of ingested calories after meals. Its efficacy for inducing weight loss has been shown. This study aimed to assess the effect of AT on obesity-related comorbidities. Methods: A meta-analysis of studies that assessed AT outcomes was conducted through December 2018. Primary outcomes were changes in comorbidities at 1 year following AT. Secondary outcomes were the amount of weight loss at up to 4 years and pooled serious adverse events (SAEs). Results: Five studies with 590 patients were included. At 1 year, there were improvements in metabolic conditions: mean difference (MD) in systolic blood pressure: -7.8 (-10.7 ? -4.9) mm Hg; MD in diastolic blood pressure: -5.1 (-7.0 ? 3.2) mm Hg; MD in triglycerides: -15.8 (-24.0 ? -7.6) mg/dL; MD in high-density lipoprotein: 3.6 (0.7?6.6) mg/dL; MD in hemoglobin A1c (HbA1c): -1.3 (-1.8 ? -0.8) %; MD in aspartate transaminase: -2.7 (-4.1 ? -1.3) U/L; MD in alanine transaminase: -7.5 (-9.8 ? -5.2) U/L. At 1 (n=218), 2 (n=125), 3 (n=46), and 4 (n=27) years, the patients experienced 17.8%, 18.3%, 19.1%, and 18.6% total weight loss (TWL), corresponding to 46.3%, 46.2%, 48.0%, and 48.7% excess weight loss (EWL) (p<0.0001 for all). Subgroup analysis of 2 randomized controlled trials (n=225) showed that AT patients lost more weight than did controls by 11.6 (6.5?16.7) %TWL and 25.6 (16.0?35.3) %EWL and experienced greater improvement in HbA1c and alanine transaminase by 1.3 (0.8?1.8) % and 9.0 (3.9?14.0) U/L. The pooled SAE rate was 4.1%. Conclusions: Obesity-related comorbidities significantly improved at 1 year following AT. Additionally, a subgroup of patients who continued to use AT appeared to experience significant weight loss that persisted up to at least 4 years.

목차

등록된 정보가 없습니다.

참고문헌 (32)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0